Expertise:
HIPEC, Robotic Surgery
Speciality:
Surgical Oncology
Gender:
Male
Language:
English

About Dr. Mohamed Adam

Dr. Mohamed Adam leads UCSF’s surgical oncology team, treating peritoneal mesothelioma and gastrointestinal tumors. His expertise includes cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for asbestos-related peritoneal cancers. He balances advanced surgical techniques with patient-focused care to improve survival and quality of life. 

As director of Peritoneal Surface Malignancies at UCSF, Dr. Adam leads a prominent research group dedicated to advancing treatments for peritoneal cancers. He has authored more than 150 publications and serves on national guidelines committees for appendiceal cancer, bringing cutting-edge research insights directly into patient care.

Medical Education & Expertise

  • UCSF Medical Center
  • Duke University (Fellowship)
  • University of Pittsburgh Medical Center (Fellowship)
  • Duke University (Residency)
  • Omdurman Islamic University, Sudan (M.D.)

Associations, Awards & Recognition

  • Board Certified, American Board of Surgery 
  • Member, National Guidelines for Appendiceal and Peritoneal Cancers

Why Choose Dr. Mohamed Adam for Peritoneal or Gastrointestinal Cancers?

Dr. Adam specializes in mesothelioma and asbestos-related peritoneal cancers, offering expert surgical care through advanced HIPEC procedures and minimally invasive techniques. He leads a multidisciplinary team that customizes treatment strategies to each patient’s unique needs.

His active research drives innovations in peritoneal cancer treatment, improving outcomes for patients with mesothelioma. Dr. Adam combines cutting-edge surgical expertise with compassionate care focused on extending and enhancing life.

Publications of Dr. Mohamed Adam

Adam, M. et al. (2025, April). Systemic Therapy and Surgical Management of Peritoneal Mesothelioma. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40015803/

Adam, M. et al. (2025, February). ASO Author Reflections: Innovative Robot-Assisted Endoluminal Resection for Gastroesophageal Junction Leiomyomas. Retrieved from https://link.springer.com/article/10.1245/s10434-024-16613-x 

Adam, M. et al. (2023, November). A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data. Retrieved from https://link.springer.com/article/10.1245/s10434-023-14041-x 

Adam, M. et al. (2023, March). Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?. Retrieved from https://onlinelibrary.wiley.com/doi/10.1007/s00268-022-06835-z 

Adam, M. et al. (2022, March). Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis. Retrieved from https://link.springer.com/article/10.1245/s10434-021-10984-1